AIM2 overexpression has been shown to increase tumor growth and invasion into lymphatic vessels by promoting EMT that is a critical process for cancer metastasis, which lead to decreased survival rates in affected individuals (Figure 3, right panels) (92). This evidence concerns the gene AIM2 and cancer.